ITOG Announces 2026 Gagel Award Recipients

The International Thyroid Oncology Group (ITOG) is pleased to announce that Dr. Saad Kenderian and Dr. Al Copland of Mayo Clinic have been selected as the recipients of the 2026 Gagel Award for their collaborative research project, “Optimized CAR T-Cell Therapy for Thyroid Cancer.”

The Gagel Award supports innovative research aimed at advancing our understanding of thyroid cancer and developing new approaches to improve patient outcomes. The selected project reflects ITOG’s commitment to supporting promising scientific investigations with the potential to advance the field of thyroid oncology.

This year’s award cycle saw a record number of applications, reflecting the growing interest and innovation within the thyroid cancer research community. Submitted proposals represented a broad spectrum of scientific and clinical inquiry, ranging from fundamental investigations into thyroid cancer biology and disease vulnerabilities to novel biomarkers and emerging therapeutic strategies.

ITOG extends its sincere appreciation to all applicants for their dedication, creativity, and commitment to advancing thyroid cancer research.

Please join us in congratulating Dr. Kenderian and Dr. Copland on this well-deserved recognition!